Genomic and phenotypic characterization of a multidrug-resistant Streptococcus pneumoniae 19 F ST320 isolate from a

Tiara Putri1,2, Budi Setiadi Daryono3, Endah Retnaningrum4

  • 1The Doctoral Program, Faculty of Biology, Universitas Gadjah Mada, Yogyakarta, Indonesia.

Scientific Reports
|April 24, 2026
PubMed

Insights

Multidrug-resistant Streptococcus pneumoniae, a significant threat in Southeast Asia, was identified in an Indonesian child. This 19F strain (ST320) shows extensive drug resistance, highlighting the need for genomic surveillance.

Area of Science:

  • Microbiology
  • Genomics
  • Epidemiology

Background:

  • Multidrug-resistant Streptococcus pneumoniae (MDR-SP) poses a significant public health challenge, particularly in Southeast Asia.
  • Genomic data on MDR-SP in Indonesia are scarce, limiting effective monitoring and control strategies.

Purpose of the Study:

  • To characterize the genomic and phenotypic features of a multidrug-resistant Streptococcus pneumoniae isolate from Indonesia.
  • To assess the potential public health implications of this isolate within the context of pediatric infections.

Main Methods:

  • Whole genome sequencing (WGS) of the pneumococcal isolate GD-BC-10.
  • Serotyping and sequence typing (ST) analysis.
  • Antimicrobial resistance profiling and virulence factor analysis.

Main Results:

  • A 19F Streptococcus pneumoniae isolate, designated GD-BC-10, was identified in a SARS-CoV-2-positive child in Yogyakarta, Indonesia.
  • The isolate belonged to sequence type 320 (ST320), part of the globally disseminated clonal complex (CC) 320/271, and exhibited resistance to multiple drug classes (β-lactams, macrolides, tetracyclines, lincosamides, folate-pathway inhibitors).
  • Genomic analysis revealed specific resistance determinants (erm(B), mef(A), tet(M), folA/folP) and virulence factors (PI-1, PI-2 pilus islets) consistent with high fitness.

Conclusions:

  • The characterized 19F ST320 strain reflects the persistence of high-risk pneumococcal clones in Indonesia.
  • Findings underscore the critical need for enhanced genomic surveillance and targeted genotypic assays for pneumococcal monitoring in pediatric populations.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease...
78
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
2.0K
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
84
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
202
Modern Molecular Taxonomy01:29

Modern Molecular Taxonomy

Advancements in molecular biology have revolutionized the identification and characterization of bacteria, with multiple methods leveraging DNA sequencing for enhanced precision. As sequencing technologies improve and costs decline, these approaches are increasingly used in clinical, environmental, and evolutionary studies.Multilocus Sequence Typing (MLST) examines several housekeeping genes, essential chromosomal genes encoding cellular functions, to distinguish strains. Approximately...
830